Virtustream Announces xStreamCare Services™ for Security and Compliance, Enabling Customers to Reduce Risks and Achieve More Proactive Security Posture
Virtustream, an enterprise-class cloud company and Dell Technologies business, announced xStreamCare Services for Security and Compliance today, bringing together advanced security management and monitoring, expert consulting services, and its innovative Trust Platform – a unified, security and compliance management platform.
Virtustream’s latest security solutions provide near real-time visibility into security alerts, intrusion attempts, open vulnerabilities, log analytics, policy management and entitlements across Virtustream’s Enterprise Cloud and Healthcare Cloud platforms, enabling enterprises to achieve a more proactive security posture to protect their business’ IT assets, applications and data.
“Setting the standards of excellence is important to our team at Benjamin Moore. Not only for our products and color offerings, but also for IT security,” said Syed Haider, Director of IT Security, Benjamin Moore. “Virtustream’s deep cloud expertise and focus on understanding our business’ needs make it an excellent fit for us. And by leveraging Virtustream’s new Trust Platform and comprehensive security services – with clear visibility all in one place – we can seamlessly address any issues or risks that may arise.”
For most customers, deploying security services is a manual process, typically managed through multiple platforms. This can be time-consuming, complex and expensive. Without a means to consolidate security data, enterprises struggle to identify their security, compliance and business risks as a whole. In fact, a recent study by Ponemon Institute1 found that 56% of businesses say data breaches occur because of a lack of visibility into the operations of their security programs.
“Our comprehensive approach to security is built on more than a decade of mission-critical cloud experience. With our new security offerings, you can eliminate the need to internally manage the growing number of complexities, cyberattacks and regulatory requirements,” says Pritesh Parekh, Chief Trust & Security Officer at Virtustream. “Our xStreamCare Services for Security and Compliance allow our customers to attain a more robust proactive security posture with unified, near real-time visibility, enabling them to quickly set priorities and make more informed security decisions with precision.”
Unified View Delivers Enhanced Insights and Faster Response Times
Virtustream’s Trust Platform aggregates and automates security data into a unified dashboard. The platform’s simplified and comprehensive view eliminates the need to manually aggregate and process logs from multiple tools and services by providing a clean, near real-time view of an enterprise’s security posture, compliance and risk across multiple workloads.
Virtustream’s Trust Platform is based on the company’s decade of experience securing mission-critical data and applications in the cloud. Further setting the new solution apart from other industry offerings are advanced features, including:
Alerts Dashboard: Displays security alerts with sensitivity levels that originate from Virtustream-deployed security controls with the ability to drill down, filter, and export data.
Vulnerability Dashboard: Prompts proactive protection through awareness of open vulnerabilities as well as their severity and age. Authorized users can define and manage aging and remediation policies.
Log Analytics: Enables ad-hoc queries against aggregated security and OS logs.
Policy Management: Supports customer-defined policies for managing security vulnerabilities.
Compliance Reporting: Allows on-demand download of available reports such as Type 2 SOC 2 + HITRUST with Cloud Security Alliance (CSA) Cloud Controls Matrix and Type 2 Attestation (AT-C 105 and AT-C 205) HIPAA/HITECH.
Asset Management Dashboard: Catalogs all assets in the cloud along with the status of security services.
The Trust Platform is available today on Virtustream Enterprise Cloud and Virtustream Healthcare Cloud.
Security Services for Every Businesses’ IT Needs
The combination of robust security features with actionable visibility helps block attacks proactively before they can penetrate a secure environment. Using security services for cloud-hosted mission-critical applications can also help increase the internal security operation team’s productivity. By off-loading management, internal IT teams can reduce the daily burden of managing security operations. Internal teams can also leverage on-demand access to certified cybersecurity experts and consulting services to address a range of potential internal skills gap.
The Security Essentials Bundle includes anti-virus/anti-malware, host intrusion detection system (IDS), host firewall, host file integrity monitoring, log management and vulnerability scanning. The Security Healthcare Bundle includes all services from the Essentials set as well as data at rest encryption and network intrusion detection. And the Enhanced Bundle includes all of these services along with log forwarding, network firewall policy auditor, data at rest encryption, operating system hardening scans, and SAP virus scanning services.
Virtustream LLC, a Dell Technologies Business, is the enterprise-class cloud company that is trusted by organizations worldwide to migrate and run their mission-critical applications in the cloud. For enterprises, service providers, healthcare organizations and government agencies Virtustream’s xStreamCare Services™ expertise combined with the Virtustream xStream® Management Platform and Infrastructure-as-a Service (IaaS) meets the security, compliance, performance, efficiency and consumption-based billing requirements of complex production applications in the cloud – whether private, public or hybrid.
Virtustream is a trademark of Virtustream LLC. Other trademarks may be trademarks of their respective owners.
1) “The Cybersecurity Illusion: The Emperor Has No Clothes,” by Ponemon Institute, published in July 2019, cited here on Nov. 6, 2019.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GPD Companies, Inc. to Acquire Distrupol22.1.2021 14:33:00 CET | Press release
GPD Companies, Inc., an affiliate of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire Distrupol, a subsidiary of Univar Solutions Inc. (NYSE: UNVR) and a leading European distributor of thermoplastics to the polymer processing industry. Terms of the transaction, which is expected to close in the first half of 2021, were not disclosed. Headquartered in Surrey, England, with broad geographic reach across Europe, Distrupol has provided value-added sales and application development of thermoplastic resins for over 50 years. Through its decades-long relationships with world class supply partners, the company offers a robust array of superior performance products and solutions that meet the needs of diverse end users from leading and emerging industries, such as the consumer, medical, automotive, and electrical sectors, among others. Distrupol caters to over 1,300 customers across 13 countries with a portfolio of over 4,0
Schlumberger Announces Fourth-Quarter and Full-Year 2020 Results22.1.2021 12:50:00 CET | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2020. Fourth-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeDec. 31, 2020Sept. 30, 2020Dec. 31, 2019SequentialYear-on-yearRevenue $5,532 $5,258 $8,228 5% -33%Income (loss) before taxes - GAAP basis $471 $(54) $452 n/m 4%Net income (loss) - GAAP basis $374 $(82) $333 n/m 12%Diluted EPS (loss per share) - GAAP basis $0.27 $(0.06) $0.24 n/m 12% Adjusted EBITDA* $1,112 $1,018 $1,648 9% -33%Adjusted EBITDA margin* 20.1% 19.4% 20.0% 73 bps 6 bpsPretax segment operating income* $654 $575 $1,006 14% -35%Pretax segment operating margin* 11.8% 10.9% 12.2% 90 bps -40 bpsNet income, excluding charges & credits* $309 $228 $545 35% -43%Diluted EPS, excluding charges & credits* $0.22 $0.16 $0.39 37% -44% Revenue by Geography International $4,343 $4,210 $5,834 3% -26%North America 1,167 1,034 2,339 13% -50%Other 22 14 55 n/m n/m $5,532 $5,258 $8,228 5% -33% *These are non-
JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)22.1.2021 07:00:00 CET | Press release
JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of "Quick and easy to operate and get high-contrast and high-resolution images". This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005316/en/ Cold Field Emission Cryo-Electron Microscope CRYO ARM(TM) 300 II (JEM-3300) (Photo: Business Wire) Development Background Recent dramatic improvement of resolution in single particle analysis (SPA) using cryo-EM has led to SPA as an essential method for structural analysis of proteins. To address this market, JEOL released the CRYO ARM™ 300 in 2017. Equipped with a cold field emission gun (Cold FEG) for enhanced resolution and a cryo-stage for loading multiple samples, the CRYO ARM™ 300 has continued to achieve best-in-class res
ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment21.1.2021 23:12:00 CET | Press release
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines — ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine— dosed once monthly, as an option to replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.1 Lynn Baxter, Head of North America, ViiV He
Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)21.1.2021 22:30:00 CET | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The BLA submission is based on data from the Phase 2 POD1UM-202 trial evaluating retifanlimab in previously treated patients with locally advanced or metastatic SCAC who have progressed on, or are intolerant of, standard platinum-based chemotherapy. The trial enrolled 94 patients, including several with well-controlled human immunodeficiency virus (HIV) infection. The study, which was recently presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, resulted in an objective response rate (ORR) of 14% for retifanlimab monotherapy as determined by inde
Wistron and Kalray Announce FURIO1200™ Storage Appliance21.1.2021 17:45:00 CET | Press release
Wistron, a leader in ICT (Information and communications technology) products, and Kalray (Paris:ALKAL) (Euronext Growth Paris: ALKAL), a leading provider in new generation of processors specialized in Intelligent Data Processing from Cloud to Edge, announce the availability of FURIO1200™, a 24-Flash-Drive NVMe-oF based storage node appliance, integrating Kalray’s NVMe-oF K200™ smart storage adapter, powered by its MPPA® Coolidge™ intelligent processor, and Wistron LYMMA chassis. FURIO1200™ is a new type of hyper-fast disaggregated storage solution delivering ultra-high throughput and reliability. It is the ideal solution for Cloud Service Providers and Enterprises running applications with intensive AI and Data Analytics workloads as well as to optimize their next generation storage. Data Centers are undergoing a very important revolution due to the explosion of usages, the surge of data to be processed and the exponential growth of the number of machines to be managed to support this
NumAlim Selects Dawex and Orange Business Services for its Data and Services Exchange Platform21.1.2021 17:40:00 CET | Press release
NumAlim announced an agreement with Dawex, the leader in Data Exchange technology, and Orange Business Services, a network-native digital services company, to deploy its agri-food digital exchange platform. By relying on these two leading players, NumAlim chose secure technological solutions guaranteeing the sovereignty of French food data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005722/en/ (Photo: Dawex) As early as Q1 2021, the NumAlim data and services exchange "Hub" will offer 18,000 companies in the food industry the opportunity to valorize, acquire and enrich all types of data: production, consumption, traceability, consumer opinions and research, as well as a wide range of services based on data (trend analysis, reformulation, regulatory watch…). "NumAlim is the answer to the needs for transparency, value creation and trust expressed by the food industry, consumers, and public authorities.” says Jérôme Fr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom